First-in-man fully leadless transvenous CRT-P with a transseptal implant of WISE-CRT ® system and Micra ® PM.

Autor: Montemerlo E; Cardiology and Electrophysiology Unit, San Gerardo Hospital, Monza, Italy., Pozzi M; Cardiology and Electrophysiology Unit, San Gerardo Hospital, Monza, Italy., De Ceglia S; Cardiology and Electrophysiology Unit, San Gerardo Hospital, Monza, Italy., Santini F; Cardiology and Electrophysiology Unit, San Gerardo Hospital, Monza, Italy., Piazzi E; Cardiology and Electrophysiology Unit, San Gerardo Hospital, Monza, Italy., Rovaris G; Cardiology and Electrophysiology Unit, San Gerardo Hospital, Monza, Italy.
Jazyk: angličtina
Zdroj: Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2019 Nov; Vol. 42 (11), pp. 1489-1492. Date of Electronic Publication: 2019 Jun 30.
DOI: 10.1111/pace.13750
Abstrakt: We describe the world's first fully leadless cardiac resynchronization therapy pacing implant with transseptal approach, in a patient with pacemaker dependency, atrial fibrillation, ischemic hypokinetic cardiomyopathy, and a history of pocket infections. After lead extraction, we implanted a MicraTranscathether Pacing System® (Medtronic, Minneapolis, MN, USA) as the sole right ventricular pacemaker, and the WISECRT system (EBR Systems, Sunnyvale, CA, USA) to provide biventricular pacing. We performed the WISECRT implant procedure using the transseptal approach given the presence of a prosthetic aortic mechanical valve, achieving satisfactory periprocedural results.
(© 2019 Wiley Periodicals, Inc.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje